The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Helicobacter Pylori Infection Treatment Market Research Report 2025
Synopsis
The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.
The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.
The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.
Global Helicobacter Pylori Infection Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Helicobacter Pylori Infection Treatment market research.
Key companies engaged in the Helicobacter Pylori Infection Treatment industry include Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma and Takeda Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Helicobacter Pylori Infection Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Helicobacter Pylori Infection Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Helicobacter Pylori Infection Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cumberland Pharmaceuticals
Eisai Co.
Bio-Rad Laboratories
F. Hoffmann-La Roche
Alpha Laboratories
Biohit
Phathom Pharmaceuticals
Redhill Biopharma
Takeda Pharmaceuticals
AbbVie
Segment by Type
Bismuth-quadruple Therapy
Concomitant Therapy
Levofloxacin Triple Therapy
Bismuth Therapy
High-dose Dual Therapy
Segment by Application
Hospitals
Diagnostics Laboratories
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Helicobacter Pylori Infection Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.
The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.
The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.
Global Helicobacter Pylori Infection Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Helicobacter Pylori Infection Treatment market research.
Key companies engaged in the Helicobacter Pylori Infection Treatment industry include Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma and Takeda Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Helicobacter Pylori Infection Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Helicobacter Pylori Infection Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Helicobacter Pylori Infection Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cumberland Pharmaceuticals
Eisai Co.
Bio-Rad Laboratories
F. Hoffmann-La Roche
Alpha Laboratories
Biohit
Phathom Pharmaceuticals
Redhill Biopharma
Takeda Pharmaceuticals
AbbVie
Segment by Type
Bismuth-quadruple Therapy
Concomitant Therapy
Levofloxacin Triple Therapy
Bismuth Therapy
High-dose Dual Therapy
Segment by Application
Hospitals
Diagnostics Laboratories
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Helicobacter Pylori Infection Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helicobacter Pylori Infection Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bismuth-quadruple Therapy
1.2.3 Concomitant Therapy
1.2.4 Levofloxacin Triple Therapy
1.2.5 Bismuth Therapy
1.2.6 High-dose Dual Therapy
1.3 Market by Application
1.3.1 Global Helicobacter Pylori Infection Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Helicobacter Pylori Infection Treatment Market Perspective (2018-2029)
2.2 Helicobacter Pylori Infection Treatment Growth Trends by Region
2.2.1 Global Helicobacter Pylori Infection Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Helicobacter Pylori Infection Treatment Historic Market Size by Region (2018-2023)
2.2.3 Helicobacter Pylori Infection Treatment Forecasted Market Size by Region (2024-2029)
2.3 Helicobacter Pylori Infection Treatment Market Dynamics
2.3.1 Helicobacter Pylori Infection Treatment Industry Trends
2.3.2 Helicobacter Pylori Infection Treatment Market Drivers
2.3.3 Helicobacter Pylori Infection Treatment Market Challenges
2.3.4 Helicobacter Pylori Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Helicobacter Pylori Infection Treatment Players by Revenue
3.1.1 Global Top Helicobacter Pylori Infection Treatment Players by Revenue (2018-2023)
3.1.2 Global Helicobacter Pylori Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Helicobacter Pylori Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Helicobacter Pylori Infection Treatment Revenue
3.4 Global Helicobacter Pylori Infection Treatment Market Concentration Ratio
3.4.1 Global Helicobacter Pylori Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helicobacter Pylori Infection Treatment Revenue in 2022
3.5 Helicobacter Pylori Infection Treatment Key Players Head office and Area Served
3.6 Key Players Helicobacter Pylori Infection Treatment Product Solution and Service
3.7 Date of Enter into Helicobacter Pylori Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Helicobacter Pylori Infection Treatment Breakdown Data by Type
4.1 Global Helicobacter Pylori Infection Treatment Historic Market Size by Type (2018-2023)
4.2 Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Type (2024-2029)
5 Helicobacter Pylori Infection Treatment Breakdown Data by Application
5.1 Global Helicobacter Pylori Infection Treatment Historic Market Size by Application (2018-2023)
5.2 Global Helicobacter Pylori Infection Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Helicobacter Pylori Infection Treatment Market Size (2018-2029)
6.2 North America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Helicobacter Pylori Infection Treatment Market Size by Country (2018-2023)
6.4 North America Helicobacter Pylori Infection Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Helicobacter Pylori Infection Treatment Market Size (2018-2029)
7.2 Europe Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2018-2023)
7.4 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size (2018-2029)
8.2 Asia-Pacific Helicobacter Pylori Infection Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Helicobacter Pylori Infection Treatment Market Size (2018-2029)
9.2 Latin America Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2018-2023)
9.4 Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size (2018-2029)
10.2 Middle East & Africa Helicobacter Pylori Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Company Detail
11.1.2 Cumberland Pharmaceuticals Business Overview
11.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Introduction
11.1.4 Cumberland Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.1.5 Cumberland Pharmaceuticals Recent Development
11.2 Eisai Co.
11.2.1 Eisai Co. Company Detail
11.2.2 Eisai Co. Business Overview
11.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Introduction
11.2.4 Eisai Co. Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.2.5 Eisai Co. Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Introduction
11.3.4 Bio-Rad Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Alpha Laboratories
11.5.1 Alpha Laboratories Company Detail
11.5.2 Alpha Laboratories Business Overview
11.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Introduction
11.5.4 Alpha Laboratories Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.5.5 Alpha Laboratories Recent Development
11.6 Biohit
11.6.1 Biohit Company Detail
11.6.2 Biohit Business Overview
11.6.3 Biohit Helicobacter Pylori Infection Treatment Introduction
11.6.4 Biohit Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.6.5 Biohit Recent Development
11.7 Phathom Pharmaceuticals
11.7.1 Phathom Pharmaceuticals Company Detail
11.7.2 Phathom Pharmaceuticals Business Overview
11.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Introduction
11.7.4 Phathom Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.7.5 Phathom Pharmaceuticals Recent Development
11.8 Redhill Biopharma
11.8.1 Redhill Biopharma Company Detail
11.8.2 Redhill Biopharma Business Overview
11.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Introduction
11.8.4 Redhill Biopharma Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.8.5 Redhill Biopharma Recent Development
11.9 Takeda Pharmaceuticals
11.9.1 Takeda Pharmaceuticals Company Detail
11.9.2 Takeda Pharmaceuticals Business Overview
11.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Introduction
11.9.4 Takeda Pharmaceuticals Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.9.5 Takeda Pharmaceuticals Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Helicobacter Pylori Infection Treatment Introduction
11.10.4 AbbVie Revenue in Helicobacter Pylori Infection Treatment Business (2018-2023)
11.10.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
